awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37404382-1112BBAF-E172-41B7-90FA-1F00093E99CC
Q37404382-1112BBAF-E172-41B7-90FA-1F00093E99CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37404382-1112BBAF-E172-41B7-90FA-1F00093E99CC
Clinical efficacy of targeted biologic agents as second-line therapy of advanced thyroid cancer.
P2860
Q37404382-1112BBAF-E172-41B7-90FA-1F00093E99CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37404382-1112BBAF-E172-41B7-90FA-1F00093E99CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c82ca5544d591beb4f07281a37cb3e4d98a17e64
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr